Albert Bourla Elected to Pfizer’s Board of Directors
23 Fevereiro 2018 - 10:00AM
Business Wire
Pfizer Inc. today announced the election of Albert Bourla, DVM,
Ph.D. to its Board of Directors, effective immediately.
Dr. Bourla, age 56, is currently the Chief Operating Officer
(COO) of Pfizer. Prior to assuming the role of COO in 2018, he was
the Group President of Pfizer Innovative Health, responsible for
the Consumer Healthcare, Inflammation and Immunology, Internal
Medicine, Oncology, Rare Disease and Vaccines business groups.
Dr. Bourla joined Pfizer in 1993, and has held a number of
senior global positions in several markets across several
disciplines, including: Group President, Global Vaccines, Oncology
and Consumer Healthcare business; President and General Manager,
Established Products; Area President of Europe, Africa, Middle
East, Asia and Pacific, Animal Health; and Vice President, Business
Development and New Products, Animal Health.
Dr. Bourla is a doctor of Veterinary Medicine and holds a Ph.D.
in Biotechnology of Reproduction from the Veterinary School of
Aristotle University. He is a member of the Board of Directors of
the Pfizer Foundation and the Biotechnology Innovation Organization
(BIO), where he serves on the Executive Committee.
About Pfizer Inc.
At Pfizer, we apply science and our global resources to bring
therapies to people that extend and significantly improve their
lives. We strive to set the standard for quality, safety and value
in the discovery, development and manufacture of health care
products. Our global portfolio includes medicines and vaccines as
well as many of the world's best - known consumer health care
products. Every day, Pfizer colleagues work across developed and
emerging markets to advance wellness, prevention, treatments and
cures that challenge the most feared diseases of our time.
Consistent with our responsibility as one of the world's premier
innovative biopharmaceutical companies, we collaborate with health
care providers, governments and local communities to support and
expand access to reliable, affordable health care around the world.
For more than 150 years, we have worked to make a difference for
all who rely on us. We routinely post information that may be
important to investors on our website at www.pfizer.com. In
addition, to learn more, please visit us on www.pfizer.com and
follow us on Twitter at @Pfizer and @Pfizer_News, LinkedIn, YouTube
and like us on Facebook at Facebook.com/Pfizer.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180223005286/en/
Pfizer Inc.Media:Joan
Campion, 212-733-2798orInvestors:Ryan Crowe,
212-733-8160
Pfizer (NYSE:PFE)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Pfizer (NYSE:PFE)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024